<DOC>
	<DOCNO>NCT02463851</DOCNO>
	<brief_summary>The GOLD FORCE trial investigates difference treatment Contact Force single-tip catheter PVAC GOLD multielectrode catheter cardiac ablation procedure patient paroxysmal atrial fibrillation .</brief_summary>
	<brief_title>PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation Pulmonary Veins Treatment Drug Refractory Symptomatic Paroxysmal Persistent Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . History symptomatic paroxysmal atrial fibrillation define : Selfterminating AF episode last seven consecutive day spontaneous conversion back sinus rhythm Documentation one event PAF tracing ECG , event recording , pacemaker strip monitor rhythm strip within past year AF symptom define manifestation following : Palpitations Fatigue Exertional dyspnea Effort intolerance 2 . Age 18 70 Willingness , ability commitment participate baseline followup evaluation full length study 1 . Structural heart disease clinical significance include : Previous cardiac surgery ( exclude CABG ) Symptoms congestive heart failure include , limited , NYHA Class III IV CHF and/or document ejection fraction &lt; 40 % measure acceptable cardiac testing Left atrial diameter &gt; 45mm measure parasternal long axis transthoracic echocardiogram LA volume &gt; 40 ml/m2 Stable/unstable angina ongoing myocardial ischemia Myocardial infarction ( MI ) within three month enrollment Aortic mitral valve disease &gt; Grade II Congenital heart disease ( include ASD PFO without right left shunt ) underlie abnormality increase risk ablative procedure Prior ASD PFO closure device use percutaneous approach Hypertrophic cardiomyopathy ( LV wall thickness &gt; 1.5 cm ) Pulmonary hypertension ( mean systolic PA pressure &gt; 50mm Hg Doppler echo 2 . Prior ablation arrhythmia AF within past three month 3 . Prior leave sided AF ablation 4 . Enrollment ongoing arrhythmia study protocol Any ventricular tachyarrhythmias currently treat arrhythmia management may interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Ablation</keyword>
	<keyword>Multi-electrode catheter PVAC</keyword>
	<keyword>Single-tip catheter Contact Force</keyword>
	<keyword>Holter</keyword>
</DOC>